Non-equity Assistance Funded Startups in United Kingdom
Across the 17 most recent United Kingdom non-equity assistance rounds shown, the only disclosed amount is $100K, appearing repeatedly for Hormona (2022-03-…
Across the 17 most recent United Kingdom non-equity assistance rounds shown, the only disclosed amount is $100K, appearing repeatedly for Hormona (2022-03-21), Hormonious Flo (2022-03-21), MyARC (2022-03-21), Played (2022-03-21), AGAM International (2022-01-13), Everknock (2022-01-13), Monva (2022-01-13), The Stack World (2021-12-10), and Neucruit (2021-12-08). That means no disclosed round exceeds $100K, and there is no disclosed “ladder” of sizes to compare beyond this single disclosed level; the remaining 8 entries list undisclosed amounts (e.g., MiiCare on 2022-10-01 and tripAbrood on 2021-10-05).
The timing concentrates heavily in a narrow window: 5 of the 17 rounds fall on 2022-03-21 (four at $100K plus a $100K-linked set across multiple companies), and a further cluster occurs on 2022-01-13 (AGAM International, Everknock, and Monva at $100K). Geographically, London dominates the page (most companies headquartered in London across 2022-10-01 down to 2021-10-05), with the main non-London exceptions being Manchester (Automedi, Phagenesis), Cambridge (52 North Health), Wales/Cumbria-region (Everknock), and Wrexham (Monva).
Most recent rounds
17 shownRelated listings
Frequently asked
What’s the largest disclosed non-equity assistance amount in this UK list, and how does it compare to other disclosed rounds?
The largest disclosed amount is $100K, held by multiple rounds including Hormona on 2022-03-21 and The Stack World on 2021-12-10. No other disclosed amount appears above $100K, while 8 of 17 entries are marked undisclosed (e.g., MiiCare on 2022-10-01; tripAbrood on 2021-10-05).
Do the dates cluster in a specific window rather than being evenly spread?
Yes. Five rounds are dated 2022-03-21 (Hormona, Hormonious Flo, MyARC, Played, all at $100K), and three rounds are dated 2022-01-13 (AGAM International, Everknock, Monva), also all at $100K. Outside those peaks, the page shows single-date entries such as MiiCare on 2022-10-01 and tripAbrood on 2021-10-05.
Which cities show up most across these non-equity assistance rounds?
London is the clear concentration point: examples include MiiCare (2022-10-01), Dama Health (2022-09-14), Plumis (2022-08-01), and AGAM International (2022-01-13), among many others. Non-London locations are fewer and more specific—Manchester (Automedi 2022-08-01; Phagenesis 2022-06-07), Cambridge (52 North Health 2022-06-07), and Wrexham (Monva 2022-01-13).
Are any sectors over-represented in this set of 17?
‘Health Care’ appears frequently (Automedi 2022-08-01; 52 North Health 2022-06-07; MyARC 2022-03-21), and ‘Financial Services’ also repeats (AGAM International 2022-01-13; Monva 2022-01-13). Several other categories appear only once (e.g., Biotechnology: Phagenesis on 2022-06-07 and Neucruit on 2021-12-08).
Is there a standout geography or sector outlier among disclosed amounts?
Because all disclosed amounts are $100K, the main “outlier” comes from the concentration pattern rather than size. For instance, Financial Services rounds are tightly clustered in London on 2022-01-13 (AGAM International and Monva, both at $100K), while the smallest set of disclosed-size coverage outside London includes Everknock listed as ‘Wales, Cumbria’ (2022-01-13) at $100K.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.